Promote the individualized chronic disease management of RA from four dimensions to achieve "long-term security"

*Only for medical professionals to read for reference.
How to individualize chronic disease management for RA patients? References: [1]Jin S,Li M,Fang Y,et al.
Chinese Registry of rheumatoid arthritis (CREDIT):II.
prevalence and risk factors of major comorbidities in Chinese patients with rheumatoid arthritis[J].
Arthritis Research & Therapy ,2017,19(1):251.
[2]Yu C, Li M, Duan X, et al.
Chinese registry of rheumatoid arthritis (CREDIT): I.
Introduction and prevalence of remission in Chinese patients with rheumatoid arthritis[J] .
Clin Exp Rheumatol,2018,36(5):836-840.
[3] National Nursing Cooperative Group for Chronic Disease Management of Rheumatoid Immune Diseases.
Expert consensus on chronic disease management of patients with rheumatoid arthritis (2014 edition)[J].
Journal of Rheumatology,2016,20(2):127-131.
[4]Bakker MF,Jacobs JW,Welsing PM,et al.
Early clinical response to treatment predicts 5-year outcome in RA patients:follow-up results from the CAMERA study[J].
Ann Rheum Dis,2011,70(6):1099-103.
[5],